Case reports, which are defined as scientific documentation of a single clinical observation, have a long and distinguished history in medicine and scientific publication. Case reports are a significant, timely, and relevant study design in the advancement of medical scientific knowledge, particularly in the field of rare diseases. While case study methodology has clear limitations in terms of determining treatment and developing new tests, the observation of a single patient can contribute to our understanding of the aetiology, pathogenesis, natural history, and treatment of particularly rare diseases, as well as the training of future junior investigators. In recent years, this type of scientific publication has come under fire from some in the medical scientific publishing community, and case studies have been pushed to the bottom of the research design hierarchy. Case reports are the simplest form of evidence, but they are also the first line of evidence because they are where new issues and ideas develop. The significance of the observation being reported will be obvious in a strong case report. A medical case report, often known as a case study, is a comprehensive account of a patient encounter. The most crucial part of a case report, and the reason you'd care to write one, is that the situation is sufficiently unique, rare, or intriguing that other medical professionals can learn from it.
Title : The foundation for rare disease and its role in the european rare disease research landscape
Daniel Scherman, Foundation for Rare Diseases, France
Title : The effect of Eupalinolide B on amyotrophic lateral sclerosis: A case report
Wang Huaixiu, Shanxi Provincial Hospital, China
Title : Progress related in genetic research on kawasaki disease
Jiao Fuyong, Shaanxi Provincial People’s Hospital, China
Title : Covid-19 seems to be Initiated by the heparan-sulfate dysregulation by coronavirus: The use of low-molecular- weight heparin (LMWH) can prevent and treat covid-19 when it Is used in early stages, as a heparan-sulfate-regulating medicine
Fereshteh Sedaghat, Sedaghat Memory Clinic, Iran (Islamic Republic of)
Title : Lumevoq gene therapy in leber hereditary optic neuropathy
Magali Taiel, GenSight Biologics, France
Title : Drug recommendation system using a collaborative filtering in machine learning
J. Somasekar, Jain University, India